PMID: 6974386Mar 1, 1981Paper

A study of the pneumococcal vaccine in prevention of clinically acute atttacks of recurrent otitis media

Reviews of Infectious Diseases
P H MäkeläP Karma

Abstract

A total of 827 infants and children three months to six years of age were vaccinated randomly after an attack of otitis media, with either the 14-valent pneumococcal vaccine or a control vaccine against Hemophilus influenzae type b. Clinically acute attacks of otitis media that occurred greater than or equal to 14 days after vaccination were analyzed by culture of the middle ear fluid. Children who had received the pneumococcal vaccine at the age of seven to 83 months experienced within the first six months after vaccination significantly fewer attacks of otitis media caused by Streptococcus pneumoniae than did children in the control group (50% overall reduction, p less than 0.01). The reduction of attacks was specific to those pneumococcal types/groups present in the vaccine that induced a good serum antibody response; the specific protection indicated for vaccine types/groups other than 6 (to which the antibody response was very poor) was 67% (P less than 0.001). No or very little protection was seen in infants younger than seven months or in any children later than six months after vaccination.

Citations

Apr 16, 2009·Current Infectious Disease Reports·Timothy F Murphy
Jan 1, 1991·Transactions of the Royal Society of Tropical Medicine and Hygiene·P H Mäkelä
Apr 13, 1999·Infectious Disease Clinics of North America·H Ahmad, E K Chapnick
Jul 18, 2002·Scandinavian Journal of Immunology·T Wuorimaa, H Käyhty
Jun 10, 1982·The New England Journal of Medicine·R D Feigin
Feb 1, 1996·Annals of Medicine·T Heikkinen, O Ruuskanen
Nov 1, 2000·Pediatric Annals·S Black, H Shinefield
Jul 1, 1989·International Journal of Pediatric Otorhinolaryngology·K PrellnerV A Oxelius
Jul 1, 1986·The Journal of Pediatrics·D McLellan, G S Giebink
Jul 20, 2001·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·B Shields
Jun 1, 1997·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Philippe Reinert
Sep 28, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D AkdumanF N Judson
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W P HausdorffG R Siber
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W P HausdorffG R Siber
Apr 9, 2005·Journal of Paediatrics and Child Health·Grant A MackenzieAmanda Jane Leach
Feb 22, 2005·Annals of Tropical Paediatrics·Fiona M Russell, E K Mulholland
Jul 1, 1986·Acta paediatrica Scandinavica·J RautonenP H Mäkelä
Feb 27, 1999·The Pediatric Infectious Disease Journal·R L Wasserman, R U Sorensen
Oct 26, 1999·The Pediatric Infectious Disease Journal·S I Pelton, J O Klein
Jun 12, 2003·The Pediatric Infectious Disease Journal·Masja StraetemansGerhard A Zielhuis
Jan 1, 1988·Acta Medica Scandinavica·R LindbladJ Westin
Feb 1, 1984·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology·I S AabergeE C Groeng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.